18 /100
LOW RISK
Score updated May 30, 2026

FOLD — Amicus Therapeutics Inc Dilution Risk Tracker

Track FOLD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FOLD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FOLD.
🔔 Track FOLD — Get forecast alerts →

💹 Market Data

Market Cap$4.55B
Shares Outstanding314.00M
Float311.44M
Cash$293.54M
Debt$442.36M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.0% shares (2025Q4 vs prior)
329 institutional holders · 335.16M shares
#1 BlackRock, Inc. 32.52M shares
#2 VANGUARD GROUP INC 29.70M shares
#3 HBK INVESTMENTS L P 15.25M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest21.92M
Days to Cover7.5
% of Float7.0%
FINRA data as of Apr 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
EFFECT EFFECT Apr 29, 2026
EFFECT EFFECT Apr 29, 2026
EFFECT EFFECT Apr 29, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track FOLD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FOLD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for FOLD
📊 FOLD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FOLD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.